ATEC Turns an Operating Profit as Biologics Bend the Forecast

November 3, 2026 1 min read Premium comments

Courtesy of Alphatec Holdings, Inc.

EOSAlphatec#atec3Q26 earnings report

Alphatec Holdings, Inc. gave the spine industry something useful to dissect in its third-quarter earnings: growing surgical demand, an operating profit, and a biologics problem large enough to bend the annual forecast.

Join 13,000+ Subscribers

Get unlimited access to OTW reporting, member discussions, and the weekly newsletter.

13,000+ subscribers

Every OTW article, fully unlocked
Member comments and discussion
The weekly orthopedic business briefing

React: